Objective
To define the safety of major hepatectomy for hepatocellular carcinoma (HCC) associated with cirrhosis and the selection criteria for surgery in terms of hospital mortality.
Design
Major hepatectomy for HCC in the presence of cirrhosis is considered to be contraindicated by many surgeons because the reported mortality rate is high (26% to 50%). Previous workers recommended that only selected patients with Child's A status or indocyanine green (ICG) retention at 15 minutes of less than 10% undergo major hepatectomy. A survey was made, therefore, of our patients with HCC and cirrhosis undergoing major hepatectomy between 1989 and 1994.
Setting
A tertiary referral center.
Patients
The preoperative, intraoperative, and postoperative data of 54 patients with cirrhosis who had major hepatectomy were compared with those of 25 patients with underlying chronic active hepatitis and 22 patients with normal livers undergoing major hepatectomy for HCC. The data had been prospectively collected.
Intervention
Major hepatectomy, defined as resection of two or more liver segments by Goldsmith and Woodburn nomenclature, was performed on all the patients.
Main Outcome Measure
Hospital mortality, which was defined as death within the same hospital admission for the hepatectomy.
Results
Preoperative liver function in patients with cirrhosis was worse than in those with normal livers. The intraoperative blood loss was also higher (P=.01), but for patients with cirrhosis, chronic active hepatitis, and normal livers, the hospital mortality rates (13%, 16%, and 14%, respectively) were similar. The hospital mortality rate for patients with cirrhosis in the last 2 years of the study was only 5%. Patients with cirrhosis could tolerate up to 10 L of blood loss and survive the major hepatectomy. By discriminant analysis, an ICG retention of 14% at 15 minutes was the cutoff level that could maximally separate the patients with cirrhosis with and without mortality.
Conclusion
Major hepatectomy for HCC in the presence of cirrhosis is associated with a mortality rate that is not different from the rate for patients with normal livers. An ICG retention of 14% at 15 minutes would serve as a better selection criterion than the 10% previously used.
(Arch Surg. 1995;130:198-203)
Tumor Size and Operative Risks of Extended Right-Sided Hepatic Resection for Hepatocellular Carcinoma: Implication for Preoperative Portal Vein Embolization
Chik et al.
Arch Surg 2007;142:63-69.
ABSTRACT
| FULL TEXT
RFA for Liver Tumors: Does It Really Work?
Higgins and Berger
The Oncologist 2006;11:801-808.
ABSTRACT
| FULL TEXT
The Role of Tumor Ablation in Bridging Patients to Liver Transplantation
Johnson et al.
Arch Surg 2004;139:825-830.
ABSTRACT
| FULL TEXT
Editorial: Improvement of Survival by Surgery in the Treatment of Hepatocellular Carcinoma: Evidence or Non-evidenced-based?
Adam
Ann. Surg. Oncol. 2004;11:460-461.
FULL TEXT
Value of Live Donor Liver Transplantation Experience in Major Hepatectomy for Hepatocellular Carcinoma
Chan et al.
Arch Surg 2003;138:265-271.
ABSTRACT
| FULL TEXT
Postoperative Pain Relief After Hepatic Resection in Cirrhotic Patients: The Efficacy of a Single Small Dose of Ketamine Plus Morphine Epidurally
Taura et al.
Anesth. Analg. 2003;96:475-480.
ABSTRACT
| FULL TEXT
Hand-Assisted Laparoscopic Liver Surgery
Antonetti et al.
Arch Surg 2002;137:407-412.
ABSTRACT
| FULL TEXT
Long-Term Prognosis After Resection of Hepatocellular Carcinoma Associated With Hepatitis B-Related Cirrhosis
Poon et al.
JCO 2000;18:1094-1094.
ABSTRACT
| FULL TEXT
Hepatectomy for Hepatocellular Carcinoma: The Surgeon's Role in Long-term Survival
Fan et al.
Arch Surg 1999;134:1124-1130.
ABSTRACT
| FULL TEXT
Prediction and Limitation of Hepatic Tumor Resection Without Blood Transfusion in Cirrhotic Patients
Wu et al.
Arch Surg 1998;133:1007-1010.
ABSTRACT
| FULL TEXT
